Brief: Treace Announces Preliminary, Unaudited Fourth Quarter And Full-Year 2023 Revenue
Jan 8 (Reuters) - Treace Medical Concepts Inc TMCI.O :
* TREACE ANNOUNCES PRELIMINARY, UNAUDITED FOURTH QUARTER AND
FULL-YEAR 2023 REVENUE
* PRELIMINARY REVENUE OF $61.8 MILLION TO $62.2 MILLION IN
Q4 OF
2023, AN APPROXIMATE 25% INCREASE
* PRELIMINARY REVENUE OF $186.7 MILLION TO $187.1 MILLION
FOR
FULL-YEAR 2023, AN APPROXIMATE INCREASE OF 32%
Source text for Eikon: ID:nGNXb6QjTN
Further company coverage: TMCI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Treace Medical Concepts
See all newsTreace Medical Q3 revenue falls but slightly beats expectations
Brief: Treace Medical Q3 EPS USD -0.19
Treace Medical Concepts, Inc. reports results for the quarter ended June 30 - Earnings Summary
Treace Medical Q2 revenue tops estimates on higher surgeon adoption; ups outlook
Treace Medical Concepts, Inc. expected to post a loss of 30 cents a share - Earnings Preview